App-based support for potential kidney donors
Part of Kidney & urinary clinical trials.
This study tests a mobile app that provides information and support to people considering living kidney donation. It may help you make a more informed decision about donation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are willing to be evaluated as a potential living kidney donor.
- You have a smartphone or tablet that can connect to the internet.
- You are able to take part in the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a mobile app designed to help kidney transplant patients manage their care after transplant. It may provide extra nursing support and reminders to keep you healthy.
This study tests a way to spread information on how to register as a live organ donor using social media. You may be contacted to help identify potential live kidney or liver donors, if you fit the study’s basic requirements.
This trial tests if a smartphone app can help people on dialysis get ready for a kidney transplant. You'll get support with exercise, nutrition, and emotional health.
This study tests a new way to help more people get a kidney from a live donor. It uses a mix of online and in-person tools to support patients like you.
This trial tests a pre-operative exercise program for people donating or receiving a kidney from a live donor. It aims to see if exercise before surgery can improve recovery and outcomes.
This study looks at what helps and what gets in the way when using a mobile health app to improve care for children hospitalized with acute kidney injury. It may help by improving how families and teams use tools during a serious hospital condition.
Hear when a new Transplant Donation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.